1 |
Zhao C, Zhang Y, Wang J. A meta-analysis on the diagnostic performance of (18)F-FDG and (11)C-methionine PET for differentiating brain tumors. AJNR Am J Neuroradiol 2014;35:1058-1065
DOI
|
2 |
Singhal T, Narayanan TK, Jain V, Mukherjee J, Mantil J. 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol 2008;10:1-18
DOI
|
3 |
Glaudemans AW, Enting RH, Heesters MA, Dierckx RA, van Rheenen RW, Walenkamp AM, et al. Value of 11C-methionine PET in imaging brain tumours and metastases. Eur J Nucl Med Mol Imaging 2013;40:615-635
DOI
|
4 |
Nagata T, Tsuyuguchi N, Uda T, Terakawa Y, Takami T, Ohata K. Examination of 11C-methionine metabolism by the standardized uptake value in the normal brain of children. J Nucl Med 2011;52:201-205
DOI
|
5 |
Lindholm P, Leskinen-Kallio S, Kirvela O, Nagren K, Lehikoinen P, Pulkki K, et al. Head and neck cancer: effect of food ingestion on uptake of C-11 methionine. Radiology 1994;190:863-867
DOI
|
6 |
Torii K, Tsuyuguchi N, Kawabe J, Sunada I, Hara M, Shiomi S. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas. Ann Nucl Med 2005;19:677-683
DOI
|
7 |
Tomura N, Ito Y, Matsuoka H, Saginoya T, Numazawa SI, Mizuno Y, et al. PET findings of intramedullary tumors of the spinal cord using [18F] FDG and [11C] methionine. AJNR Am J Neuroradiol 2013;34:1278-1283
DOI
|
8 |
Kawase Y, Yamamoto Y, Kameyama R, Kawai N, Kudomi N, Nishiyama Y. Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma. Mol Imaging Biol 2011;13:1284-1289
DOI
|
9 |
Okochi Y, Nihashi T, Fujii M, Kato K, Okada Y, Ando Y, et al. Clinical use of (11)C-methionine and (18)F-FDG-PET for germinoma in central nervous system. Ann Nucl Med 2014;28:94-102
DOI
|
10 |
Phi JH, Paeng JC, Lee HS, Wang KC, Cho BK, Lee JY, et al. Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet. J Nucl Med 2010;51:728-734
DOI
|
11 |
Arita H, Kinoshita M, Okita Y, Hirayama R, Watabe T, Ishohashi K, et al. Clinical characteristics of meningiomas assessed by -methionine and -fluorodeoxyglucose positron-emission tomography. J Neurooncol 2012;107:379-386
DOI
|
12 |
Takao H, Momose T, Ohtomo K. Methionine and glucose metabolism of central neurocytoma: a PET study. Clin Nucl Med 2004;29:838-839
DOI
|
13 |
Nakagawa M, Kuwabara Y, Sasaki M, Koga H, Chen T, Kaneko O, et al. 11C-methionine uptake in cerebrovascular disease: a comparison with 18F-fDG PET and 99mTc-HMPAO SPECT. Ann Nucl Med 2002;16:207-211
DOI
|
14 |
Harada Y, Hirata K, Kobayashi H, Usui R, Shiga T, Terae S, et al. A pitfall of C-11 methionine PET: cerebral venous infarction mimicked a glioma. Clin Nucl Med 2012;37:110-111
DOI
|
15 |
O'Doherty MJ, Barrington SF, Campbell M, Lowe J, Bradbeer CS. PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 1997;38:1575-1583
|
16 |
Sasaki M, Kuwabara Y, Yoshida T, Fukumura T, Morioka T, Nishio S, et al. Carbon-11-methionine PET in focal cortical dysplasia: a comparison with fluorine-18-FDG PET and technetium-99m-ECD SPECT. J Nucl Med 1998;39:974-977
|